Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Chinese Hospitals, IBM Partner on Enhancing Cancer Treatments

By Ryan Bushey | August 15, 2016

IBM’s Watson Supercomputer will play a crucial role in a new multi-year program being unveiled in China.

The company will work in conjunction with Hangzhou Cognitive Care to have Watson for Oncology incorporated into 21 hospitals.

This particular computing platform specializes in synthesizing tremendous amounts of data in order to provide physicians with a summary of patient records and numerous pieces of medical literature to help find the best individualized treatments for certain patients, according to IBM’s statement.

Hangzhou, a healthcare services organization, will assist IBM in matters like translation support because the insights delivered by Watson will initially only be available in English. Sales and customer support will also fall under Hangzhou’s purview as well. 

“Watson has the power to transform how doctors battle cancer in China and around the world, providing physicians with insights regarding treatment options that help them customize therapeutic recommendations specific to each individual, based on a patient’s specific needs,” said Zhen Tu, CEO of Hangzhou Cognitive Care, in a statement.

Another important feature built into Watson’s programming is its machine-learning capabilities, which means it will improve itself over time.

This could be a useful feature as China saw 4.3 million new cancer cases last year along with an estimated 2.8 million cancer deaths, noted FierceBiotech. Physicians are having difficulties staying up to date on emerging cancer research so Watson Oncology could prove to be a valuable hub of information.

Also, this is the first partnership IBM established in China, but not the first foray into healthcare for Watson. The technology giant signed a deal with the American Diabetes Association in June to develop a new set of research tools to understand how to prevent, diagnose, and treat diabetes.

Related Articles Read More >

Probiotics power a bioresorbable battery that can run from 4 to 100+ minutes
Korean engineers show off ultra-light prosthetic hand with single-motor thumb
2025 R&D layoffs tracker tops 92,000
Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE